| Literature DB >> 31917913 |
Jung Hwan Oh1, Joong Goo Kwon2, Hye-Kyung Jung3, Chung Hyun Tae3, Kyung Ho Song4, Seung Joo Kang5, Sung Eun Kim6, Kyoungwon Jung6, Joon Sung Kim1, Jong Kyu Park7, Ki Bae Bang8, Myong Ki Baeg9, Jeong Eun Shin8, Cheol Min Shin10, Ju Yup Lee11, Hyun Chul Lim12.
Abstract
Functional dyspepsia (FD) is a chronic upper gastrointestinal (GI) symptom complex that routine diagnostic work-up, such as endoscopy, blood laboratory analysis, or radiological examination, fails to identify a cause. It is highly prevalent in the World population, and its response to the various available therapeutic strategies is only modest because of the heterogenous nature of its pathogenesis. Therefore, FD represents a heavy medical burden for healthcare systems. We constituted a guideline development committee to review the existing guidelines on the management of functional dyspepsia. This committee drafted statements and conducted a systematic review and meta-analysis of various studies, guidelines, and randomized control trials. External review was also conducted by selected experts. These clinical practice guidelines for FD were developed based on evidence recently accumulated with the revised version of FD guidelines released in 2011 by the Korean Society of Neurogastroenterology and Motility. These guidelines apply to adults with chronic symptoms of FD and include the diagnostic role of endoscopy, Helicobacter pylori screening, and systematic review and meta-analyses of the various treatment options for FD (proton pump inhibitors, H. pylori eradication, and tricyclic antidepressants), especially according to the FD subtype. The purpose of these new guidelines is to aid the understanding, diagnosis, and treatment of FD, and the targets of the guidelines are clinicians, healthcare workers at the forefront of patient care, patients, and medical students. The guidelines will continue to be revised and updated periodically.Entities:
Keywords: Dyspepsia; Endoscopy; Evidence-based medicine; Guideline; Proton pump inhibitors
Year: 2020 PMID: 31917913 DOI: 10.5056/jnm19209
Source DB: PubMed Journal: J Neurogastroenterol Motil ISSN: 2093-0879 Impact factor: 4.924